No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bevacizumab
-
Colorectal Neoplasms / drug therapy
-
Colorectal Neoplasms / pathology*
-
Endothelial Growth Factors / immunology*
-
Fluorouracil / administration & dosage
-
Hemorrhage / chemically induced*
-
Humans
-
Intercellular Signaling Peptides and Proteins / immunology*
-
Leucovorin / administration & dosage
-
Lymphokines / immunology*
-
Neoplasm Metastasis
-
Thrombosis / chemically induced*
-
Thrombosis / prevention & control*
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Warfarin / therapeutic use*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants
-
Endothelial Growth Factors
-
Intercellular Signaling Peptides and Proteins
-
Lymphokines
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Bevacizumab
-
Warfarin
-
Leucovorin
-
Fluorouracil